Login / Signup

Safety and Effectiveness of Ustekinumab for Crohn's Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed.

Katsumasa NaganoErina HataTeita AsanoHiroaki TsuchiyaMasayuki TakagishiHiroshi YamazakiSonoko TominagaTakayuki Matsumoto
Published in: Crohn's & colitis 360 (2023)
The present study identified no new safety concerns and effectiveness for CD in Japanese patients treated with UST.
Keyphrases
  • randomized controlled trial
  • systematic review
  • rheumatoid arthritis
  • public health
  • hiv infected